16th Congress of the Cell Transplant and Regenerative Medicine Society
September 21-25, 2019 - Lesvos, Greece

Call for Abstracts


Abstract Submission Process

Late Breaking Abstract submission. Click here to submit.

(You will need to create an account prior to submission)

User Profile

  • Before submitting an abstract, the submitter must create a User Profile.
  • After an abstract has been created, modifications can be made until the submission deadline.
  • There is no limit on the number of abstract submissions from any one individual. However, we will apply a rule of three for abstract presenter (see details below).

Deadlines

The final deadline to submit the abstract(s) is March 25, 2019. Abstracts will not be able to be submitted online after this date. The submitting author will receive notification of acceptance April 30, 2019. At the time of the confirmation of acceptance of your abstract, presenters will be requested to register for the congress. Deadline for abstract confirmation of acceptance and presenter registration in May 15, 2019.

Important Dates

November 2, 2018  Abstract Submission Opens
November 22, 2018  Registration and Housing Open
March 25, 2019   Abstract Submission Deadline
April 30, 2019   Communication to authors on approved / rejected abstracts
May 15, 2019    Deadline for Early Bird registration
May 15, 2019 Deadline for presenter registration

 

Choosing a Theme

During the submission process, you will be asked to select the topic for your abstract. The topic is the general heading under which the abstract will be reviewed and later published in the congress materials, if accepted. The topic which best describes the subject of the abstract should be chosen. CTRMS reserves the right to reassign the topic of the abstract for the purposes of programming.

List of Themes / Abstract Topics (click to expand list)

    • Stem Cells
    • Cell tracking and bio-imaging
    • Cardiac Cells
    • Clinical Islet Transplantation
    • Encapsulation
    • Immunology
    • Islet Cells
    • Liver Cells
    • Muscle Cells
    • Neural Cells
    • Tissue Engineering
    • Transdifferentiation, Tissue Reprogramming and Regeneration and wound healing
    • Tolerance

Abstract Structure

Abstracts in all themes should be structured chronologically in five sections: first Introduction; then Materials and Methods; Results; and Discussion (together, these three sections make up the paper's body); and finally, Conclusion.
  • The Introduction section clarifies the motivation for the work presented and prepares readers for the structure of the paper.
  • The Materials and Methods section provides sufficient detail for other scientists to reproduce the experiments presented in the paper. In some journals, this information is placed in an appendix, because it is not what most readers want to know first.
  • The Results and Discussion sections present and discuss the research results, respectively. They are often usefully combined into one section, however, because readers can seldom make sense of results alone without accompanying interpretation — they need to be told what the results mean.
  • The Conclusion section presents the outcome of the work by interpreting the findings at a higher level of abstraction than the Discussion and by relating these findings to the motivation stated in the Introduction. Explain the significance of your findings / outcomes and future implications of the results.

Abstract Guidelines

All abstracts must be submitted electronically through the Congress abstract submission website.

  • Abstracts will be accepted in English only.
  • There is no fee for submitting an abstract.
  • There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present three abstracts (oral, mini-oral or poster) presentations during the entire Congress. If you have more than 3 abstracts accepted, you will be obliged to identify alternate co-author for any abstract above the first three.
  • The abstract text body is limited to 2,500 characters (Approx. 400 words) including spaces. A maximum of two figures/images (in JPG, GIF, or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 2 MB maximum for each figure.
  • Tables: do not insert tables into the body of the abstracts, the system will not recognize the format of the table. Tables will need to be uploaded as image files into the body of the abstract.
  • Abstracts accepted for oral, mini-oral or poster presentation will be published electronically in the official journal of The Transplantation Society.Abstracts not accepted for presentation will not be published. Abstracts will also be posted prior to the meeting in the detailed program section of the Congress website.
  • Employees of Commercial Interests: CTRMS recognizes that employees/spouses of commercial interests are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. Employees of commercial interests should submit abstracts when the content is limited to basic science research (e.g., pre-clinical research, drug discovery) or the processes/methodologies of research, themselves unrelated to a specific disease or compound/drug, and the abstract is not related to clinical applications of the research/discovery or clinical recommendations concerning the business lines or products of their employer.
  • Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed or withdrawn after March 25, 2019. Once an abstract has been scored by reviewers, no change in the body of the abstract will be accepted.

Presenters of successful abstracts must confirm their acceptance, register and pay for the Congress by May 15, 2019 (early bird fee will not apply), otherwise the abstract will not be published.

Policies For Abstract Submission

Copyright Policy

Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

Resubmission Policy

CTRMS welcomes the submission of abstracts that have been presented previously at regional, national, or international meetings in the two years since the last CTRMS Congress (2017). However, if a manuscript of the abstract has been published, submission will not be permitted.

Plagiarism

CTRMS regards plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and when identified, the abstract and any other abstracts submitted by the same author are rejected. In addition, the submitting author’s profile and scholarship application, in the case one has been submitted, will also be cancelled.

Ethics Compliance

To be eligible to submit an abstract, you must disclose that the authors/ scientists have not violated any aspect of The Transplantation Society Ethics statements and that this research conforms with the ethical statements noted.

Scientific studies and clinical activities should be performed in keeping with the ethical principles delineated in the following policy documents:

  • the Declaration of Istanbul (DOI) ethics' statement
  • the ethical statement on human research subject, Helsinki Declaration of The World Medical Association
  • the International Xenotransplantation Association Ethics Committee Position Paper on The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003) For research involving human subjects -The Helsinki
  • The Transplantation Society ethics statement
  • Institutional Ethical Review for human and/or animal research as appropriate

Abstract Review And Selection Process

Abstract Review

  • All submitted abstracts will go through a blinded peer-review process carried out by an international review committee.
  • All abstracts will be reviewed (blinded) by at least three international referees, selected by the organizing committee.
  • Abstracts which do not meet the focus of the topic category as requested by the authors will be reassigned to another category.
  • Scores assigned by all reviewers are averaged. The cut-off average score for acceptance is based on available oral and poster presentations. Rejections are further evaluated by the Scientific Program Committee.

Format of Presentation

You may opt to submit your abstract to be considered for an oral presentation, a poster presentation, or either (at the committee’s discretion).

Notification of Acceptance or Rejection to Corresponding Author

Notification of acceptance or rejection will be sent to the submitting (corresponding) author by April 30, 2019. Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

Rule of Three

Each presenting author may present a maximum of three abstracts during the entire Congress (oral, mini-orals or posters). The number of submissions is however not limited. Should an author have more than three abstracts accepted for presentation, a co-author must be named as presenter for one or more abstracts.

Congress Secretariat
The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest, Suite 1401
Montréal, QC, Canada H2Z 1Y7
This email address is being protected from spambots. You need JavaScript enabled to view it.